Indication

Female hypogonadism

Female hypogonadism is an endocrine disorder characterized by deficient ovarian function, resulting in insufficient production of sex steroids, predominantly estradiol, and impaired oocyte maturation. Read more about Female hypogonadism

70 drugs 47 manufacturers

Advertisement

Drugs that treat it

Common Female hypogonadism therapies.

Showing 19–27 of 70 drugs

Filter & compare in the drug finder →Opens the drug finder with Female hypogonadism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Female hypogonadism.

Female hypogonadism is an endocrine disorder characterized by deficient ovarian function, resulting in insufficient production of sex steroids, predominantly estradiol, and impaired oocyte maturation.

It affects female reproductive physiology across various life stages and can originate from intrinsic ovarian dysfunction, termed hypergonadotropic or primary hypogonadism, or from hypothalamic-pituitary axis failure, termed hypogonadotropic or secondary hypogonadism.

Clinically, it manifests as delayed or absent pubertal development in adolescents, and as oligomenorrhea, amenorrhea, infertility, vasomotor symptoms, and accelerated bone mineral density loss in reproductive-age and adult women.

Personalize your experience

Follow Female hypogonadism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it